GDU OP AUG

Glioblastoma: Review of Failures and Future Directions

Friday, August 12, 2022

9:10 AM – 9:45 AM

Co-Presenter(s)

Amy Ly Indorf, PharmD, BCOP

UW Medicine/Seattle Cancer Care Alliance
University of Washington School of Pharmacy
Mountlake Terrace, Washington
Lisa Modelevsky, PharmD, BCOP

Memorial Sloan Kettering Cancer Center
New York, New York

This session will focus on updates in the treatment of glioblastoma by reviewing current standard of care treatment options, as well as trials with negative outcomes in the recent past that inform our treatment decisions moving forward. As targeted therapy options in oncology grow, it influences our treatment options in glioblastoma as well. We will review the data behind targeted therapies in glioblastoma and promising trials that can change the landscape of treatment for glioblastoma.

Learning Objectives:

Identify current standard of care treatment options for glioblastoma
Review setbacks in the treatment of glioblastoma
Summarize the data behind targeted therapy options in the treatment of glioblastoma
Highlight promising trials in the treatment of glioblastoma